Literature DB >> 8013493

Characteristics of serogroup A Neisseria meningitidis strains isolated in the Central African Republic in February 1992.

M Guibourdenche1, D A Caugant, V Hervé, J M Debonne, C Lanckriet, M Merlin, C Mathiot, J B Roungou, G Martet, J Y Riou.   

Abstract

A severe epidemic of serogroup A meningococcus meningitis occurred in the northwest Central African Republic from January to March 1992. Strains from 24 patients were characterized using serotyping, testing of susceptibility to antibiotics, and multilocus enzyme electrophoresis. In 23 of the 24 patients the causal strain was found to be 4:P1.9/clone III-1. These results indicate that such strains continue to spread in Africa and have taken hold in areas outside the "meningitis belt." This may be a consequence of changing climatic conditions.

Entities:  

Mesh:

Year:  1994        PMID: 8013493     DOI: 10.1007/bf01982194

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A.

Authors:  M Achtman; B Kusecek; G Morelli; K Eickmann; J F Wang; B Crowe; R A Wall; M Hassan-King; P S Moore; W Zollinger
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

2.  Cerebrospinal meningitis in the Central African Republic.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1992-11-06

3.  Characterization of Neisseria meningitidis serogroup A strains from an outbreak in France by serotype, serosubtype, multilocus enzyme genotype and outer membrane protein pattern.

Authors:  J Y Riou; D A Caugant; R K Selander; J T Poolman; M Guibourdenche; E Collatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-05       Impact factor: 3.267

Review 4.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

5.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Characteristics of serogroup A Neisseria meningitidis responsible for an epidemic in Ethiopia, 1988-89.

Authors:  R T Haimanot; D A Caugant; D Fekadu; G Bjune; B Belete; L O Frøholm; E A Høiby; E Rosenqvist; R K Selander; B Bjorvatn
Journal:  Scand J Infect Dis       Date:  1990

7.  Outer membrane protein serosubtyping of Neisseria meningitidis.

Authors:  J T Poolman; H Abdillahi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

Review 8.  Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.

Authors:  T Olyhoek; B A Crowe; M Achtman
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

Review 9.  Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process.

Authors:  P S Moore
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

10.  Characterization of epidemic and nonepidemic Neisseria meningitidis serogroup A strains from Sudan and Sweden.

Authors:  M A Salih; D Danielsson; A Bäckman; D A Caugant; M Achtman; P Olcén
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

View more
  2 in total

1.  Pulsed-field gel electrophoresis analysis of clonal relationships among Neisseria meningitidis A strains from different outbreaks.

Authors:  P Nicolas; D Parzy; G Martet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

2.  A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995.

Authors:  J Y Riou; S Djibo; L Sangare; J P Lombart; P Fagot; J P Chippaux; M Guibourdenche
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.